Home infusion therapy Market Growth, Size, Share, Trends, and Forecast 2030

Global Home Infusion Market Overview

The global Home infusion therapy market accounted for USD 23.0 Billion in 2020 and is expected to reach USD 55.5 Billion by 2028, growing at a CAGR of around 11.2% between 2021 and 2028.      

Infusion therapy involves the administration of drug intravenously. It is prescribed when a patient’s condition is much severe and cannot be treated effectively by oral medications. Technological advances have enabled safe and effective administration of infusion therapies at home. Infusion therapy is required in several health conditions which include infections that are not responsive to oral antibiotics, cancer-related pain, dehydration, gastrointestinal disorders and much more. For individuals requiring long-term therapy, inpatient care is needed Home infusion has been proven to be a safe and effective alternative.

COVID-19 Impact Analysis

The global Home infusion therapy market has witnessed a significant growth in the sales during the COVID-19 pandemic. This is due to considerable growth in adoption rate of home infusion therapies.

Growing number of the market players are investing more on research and development in the field which is predicted to create growth opportunities in the estimated period. For instance, In April 2020, B. Braun infusion pumps receive FDA emergency use authorization with nebulizers to treat COVID-19 patients for all ages. In addition, advancement of technology is expected to create lucrative growth opportunity for the market in the forecast period. For instance in July 2020, Biocon biologics and Voluntis joined hands for global collaboration on digital therapeutics for insulins which develops as well as distributes innovative digital therapeutics supporting people with diabetes on biologics therapy. Various scenarios have been analyzed on the basis of inputs from various secondary sources and the current data available about the situation.

Request Free Sample

Growth Factors

Global home infusion therapy market is primarily driven by growing aging population and prevalence of chronic diseases such as cancer, obesity, diabetes, asthma, and other life-threatening conditions. In addition to this, the adoption of home infusion therapy products as well as services in underdeveloped and developed regions has augmented due to cost-effective treatments in the past few years, thereby fueling growth of the market

Nonetheless, rising preference for homecare facilities is likely to disclose the new avenues for home infusion therapy market in the near future.

Report Scope:

Request Free Sample

Segment Analysis Preview

Based on Product type, the market can be segmented into the infusion pump, intravenous sets, IV cannulas and needleless connectors.  Infusion pump was the major segment and it accounted the major share of total revenue generated in 2020. Needleless connectors are fastest growing segments in this market. On the basis of application type, the market is divided into anti-infectives, endocrinology, enteral nutrition, hydration therapy, chemotherapy, parenteral infusion, immunoglobulin infusion and others. Anti-infectives was the major segment and it accounted for over maximum share of total revenue generated in 2020. Enteral nutrition, parenteral infusion, and chemotherapy were the fastest growing segments in this market.

Regional Analysis Preview

The global home infusion therapy market by North America and it held a maximum share of total revenue generated in 2020. This growth can be attributed to the presence of key players and good health awareness among people. The growth is also due to a large number of chronic diseases and growing geriatric population in this region. There is a significant increase in IV based therapy drugs to treat chronic and rare diseases (including blood factors, corticosteroids, growth hormones, immunoglobulin, monoclonal therapies and others) are being infused in home settings. There is a rise in adoption of home infusion therapy in the administration of anti-infectives such as antibiotics, antiviral, antifungal drugs, chemotherapy drugs, parenteral nutrition, hydration products and pain management.

Europe is another leading regional market followed by North America on account of advanced medical facilities and growing number of specialty-pharmacy and home-infusion centers in European countries. The region has a lot to offer, as the population is more health conscious and faster adoption rate of home infusion therapy due to rise in per capita income. Asia Pacific was a fastest growing market on account of rising geriatric population, rising disposable income and increasing consumer spending towards healthcare. The region is fastest developing owing to raising awareness among people regarding the use of infusion drug therapies in hospitals and healthcare facilities. Latin America was emerging market with rising healthcare infrastructure. Brazil and rest of Latin America are anticipated to fuel the market growth in coming years.

Request Free Sample

Key Market Players & Competitive Landscape

Some of the major players of the global home infusion therapy market include Baxter, B. Braun Melsungen AG, Care Fusion Corporation, ICU Medical, Inc., Fresenius Kabi AG, JMS Co. Ltd., Terumo Corporation, Smiths Medical and Caesarea Medical Electronics among others.

Request Free Sample

The global Home Infusion Therapy Market is segmented as follows:

By Products

• Infusion Pump
• Intravenous Sets
• IV Cannulas
• Needleless Connectors

By Application Types

• Anti-Infectives

• Endocrinology
• Enteral nutrition
• Hydration Therapy
• Parenteral Nutrition

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa